Marksans Pharma Limited — Updates, 30-05-2025: Press Release

Marksans Pharma’s UK subsidiary, Relonchem, received marketing authorization for Metformin Hydrochloride 500 mg/5 ml oral solution, enhancing its anti-diabetic portfolio. This approval strengthens Marksans’ presence in the UK and regulated markets, supporting growth through specialty formulations and potentially increasing revenue from these regions.